Benefits and Prerequisites Associated with the Adoption of Oral 3D-Printed Medicines for Pediatric Patients : A Focus Group Study among Healthcare Professionals

Show simple item record

dc.contributor.author Rautamo, Maria
dc.contributor.author Kvarnström, Kirsi
dc.contributor.author Sivén, Mia
dc.contributor.author Airaksinen, Marja
dc.contributor.author Lahdenne, Pekka
dc.contributor.author Sandler, Niklas
dc.date.accessioned 2020-03-13T13:09:27Z
dc.date.available 2020-03-13T13:09:27Z
dc.date.issued 2020-03-05
dc.identifier.citation Rautamo, M.; Kvarnström, K.; Sivén, M.; Airaksinen, M.; Lahdenne, P.; Sandler, N. Benefits and Prerequisites Associated with the Adoption of Oral 3D-Printed Medicines for Pediatric Patients: A Focus Group Study among Healthcare Professionals. Pharmaceutics 2020, 12, 229.
dc.identifier.uri http://hdl.handle.net/10138/313297
dc.description.abstract The utilization of three-dimensional (3D) printing technologies as innovative manufacturing methods for drug products has recently gained growing interest. From a technological viewpoint, proof-of-concept on the performance of different printing methods already exist, followed by visions about future applications in hospital or community pharmacies. The main objective of this study was to investigate the perceptions of healthcare professionals in a tertiary university hospital about oral 3D-printed medicines for pediatric patients by means of focus group discussions. In general, the healthcare professionals considered many positive aspects and opportunities in 3D printing of pharmaceuticals. A precise dose as well as personalized doses and dosage forms were some of the advantages mentioned by the participants. Especially in cases of polypharmacy, incorporating several drug substances into one product to produce a polypill, personalized regarding both the combination of drug substances and the doses, would benefit drug treatments of several medical conditions and would improve adherence to medications. In addition to the positive aspects, concerns and prerequisites for the adoption of 3D printing technologies at hospital settings were also expressed. These perspectives are suggested by the authors to be focus points for future research on personalized 3D-printed drug products.
dc.language.iso eng
dc.publisher Multidisciplinary Digital Publishing Institute
dc.title Benefits and Prerequisites Associated with the Adoption of Oral 3D-Printed Medicines for Pediatric Patients : A Focus Group Study among Healthcare Professionals en
dc.date.updated 2020-03-13T13:09:27Z
dc.type.uri http://purl.org/eprint/entityType/JournalArticle
dc.type.uri http://purl.org/eprint/entityType/Expression
dc.type.uri http://purl.org/eprint/entityType/Expression

Files in this item

Total number of downloads: Loading...

Files Size Format View
pharmaceutics-12-00229.pdf 1.030Mb PDF View/Open

This item appears in the following Collection(s)

Show simple item record